Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Clostridium perfringens (strain 13 / Type A) | Microbial collagenase | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | muscleblind protein | 0.0167 | 0.1824 | 0.07 |
Mycobacterium tuberculosis | Probable 6-phosphofructokinase PfkA (phosphohexokinase) (phosphofructokinase) | 0.0121 | 0.1208 | 0.5 |
Schistosoma mansoni | 6-phosphofructokinase | 0.0121 | 0.1208 | 0.1208 |
Plasmodium falciparum | ATP-dependent 6-phosphofructokinase | 0.0033 | 0.0009 | 0.5 |
Trichomonas vaginalis | phosphofructokinase, putative | 0.0121 | 0.1208 | 1 |
Plasmodium vivax | 6-phosphofructokinase, putative | 0.0033 | 0.0009 | 0.5 |
Trichomonas vaginalis | phosphofructokinase, putative | 0.0121 | 0.1208 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0167 | 0.1824 | 1 |
Leishmania major | ATP-dependent phosphofructokinase | 0.0121 | 0.1208 | 0.5 |
Trichomonas vaginalis | phosphofructokinase, putative | 0.0121 | 0.1208 | 1 |
Plasmodium falciparum | ATP-dependent 6-phosphofructokinase | 0.0033 | 0.0009 | 0.5 |
Entamoeba histolytica | phosphofructokinase, putative | 0.0121 | 0.1208 | 1 |
Mycobacterium ulcerans | 6-phosphofructokinase | 0.0121 | 0.1208 | 0.5 |
Chlamydia trachomatis | fructose-6-phosphate phosphotransferase | 0.0033 | 0.0009 | 0.5 |
Echinococcus multilocularis | muscleblind protein 1 | 0.0167 | 0.1824 | 0.07 |
Entamoeba histolytica | phosphofructokinase, putative | 0.0121 | 0.1208 | 1 |
Echinococcus multilocularis | geminin | 0.0189 | 0.2127 | 0.1045 |
Schistosoma mansoni | 6-phosphofructokinase | 0.0121 | 0.1208 | 0.1208 |
Mycobacterium leprae | PROBABLE 6-PHOSPHOFRUCTOKINASE PFKA (PHOSPHOHEXOKINASE) (PHOSPHOFRUCTOKINASE) | 0.0121 | 0.1208 | 0.5 |
Toxoplasma gondii | phosphofructokinase PFKII | 0.0033 | 0.0009 | 0.5 |
Giardia lamblia | Pyrophosphate-fructose 6-phosphate 1-phosphotransferase alpha subunit | 0.0033 | 0.0009 | 0.5 |
Trypanosoma brucei | ATP-dependent 6-phosphofructokinase, glycosomal | 0.0121 | 0.1208 | 0.5 |
Trichomonas vaginalis | phosphofructokinase, putative | 0.0121 | 0.1208 | 1 |
Chlamydia trachomatis | fructose-6-phosphate phosphotransferase | 0.0033 | 0.0009 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | extracellular metallopeptidase | 0.0365 | 0.4517 | 0.5 |
Trypanosoma cruzi | ATP-dependent 6-phosphofructokinase, glycosomal | 0.0121 | 0.1208 | 0.5 |
Brugia malayi | Muscleblind-like protein | 0.0167 | 0.1824 | 1 |
Echinococcus granulosus | muscleblind protein | 0.0167 | 0.1824 | 0.07 |
Toxoplasma gondii | phosphofructokinase domain-containing protein | 0.0033 | 0.0009 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0167 | 0.1824 | 1 |
Plasmodium vivax | 6-phosphofructokinase, putative | 0.0033 | 0.0009 | 0.5 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0769 | 1 | 1 |
Echinococcus granulosus | geminin | 0.0189 | 0.2127 | 0.1045 |
Toxoplasma gondii | 6-phosphofructokinase | 0.0033 | 0.0009 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0189 | 0.2127 | 0.2127 |
Entamoeba histolytica | phosphofructokinase, putative | 0.0121 | 0.1208 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0189 | 0.2127 | 0.2127 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0769 | 1 | 1 |
Treponema pallidum | diphosphate--fructose-6-phosphate 1-phosphotransferase | 0.0121 | 0.1208 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 11 uM | Inhibition of Clostridium histolyticum collagenase using a linear regression program | ChEMBL. | 10743957 |
Ki (binding) | = 11 uM | Inhibition of Clostridium histolyticum collagenase using a linear regression program | ChEMBL. | 10743957 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.